CALM Stock Analysis: Cal-Maine Foods | NASDAQ
Farm Products | NASDAQ, USA | Market Cap: 3.104m USD | 12M Return: -23.4% | US1280302027 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 61.4M
EPS Trend: -11.0%
Qual. Beats: 0
Rev. Trend: 40.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Cal-Maine Foods, Inc. (NASDAQ: CALM) is a U.S. producer and distributor of shell eggs, egg products, and prepared foods, operating through three segments: Conventional Shell Eggs, Specialty Shell Eggs, and Prepared Foods. The company offers specialty offerings such as cage-free, organic, brown, free-range, pasture-raised, and nutritionally enhanced eggs, alongside conventional and co-pack shell eggs, as well as prepared items including pre-cooked egg patties, omelets, hard-cooked eggs, pancakes, waffles, and specialty wraps.
The company markets products under brands including Egg-Lands Best, Land O Lakes, Farmhouse Eggs, Sunups, 4Grain, Vans, MeadowCreek Foods, and Crepini, selling to national and regional grocery chains, club stores, independent supermarkets, foodservice distributors, and egg product consumers. Founded in 1957, Cal-Maine is headquartered in Ridgeland, Mississippi, and has been publicly traded since its 1996 IPO.
Cal-Maine operates within the Consumer Staples sector (Packaged Foods & Meats sub-industry), where egg producers typically benefit from stable, recurring demand driven by eggs role as an affordable, everyday protein source. The U.S. shell egg industry is highly consolidated, with a small number of large producers accounting for the majority of commercial supply.
- Avian flu outbreaks tighten shell egg supply and prices
- Cage-free egg mandates lift specialty segment pricing power
- Corn and soybean meal costs pressure conventional egg margins
| Net Income: 58.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -39.07 > 1.0 |
| NWC/Revenue: 50.65% < 20% (prev 35.85%; Δ 14.80% < -1%) |
| CFO/TA 0.03 > 3% & CFO 103.0m > Net Income 58.7m |
| Net Debt (-766.1m) to EBITDA (145.5m): -5.27 < 3 |
| Current Ratio: 7.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.7m) vs 12m ago -3.55% < -2% |
| Gross Margin: 14.28% > 18% (prev 43.54%; Δ -29.25% > 0.5%) |
| Asset Turnover: 81.44% > 50% (prev 137.6%; Δ -56.17% > 0%) |
| Interest Coverage Ratio: 31.03 > 6 (EBIT TTM 17.3m / Interest Expense TTM 556k) |
| A: 0.43 (Total Current Assets 1.47b - Total Current Liabilities 191.1m) / Total Assets 3.01b |
| B: 0.90 (Retained Earnings 2.71b / Total Assets 3.01b) |
| C: 0.01 (EBIT TTM 17.3m / Avg Total Assets 3.10b) |
| D: 5.93 (Book Value of Equity 2.57b / Total Liabilities 433.4m) |
| Altman-Z'' = 11.98 = AAA |
| DSRI: 2.02 (Receivables 285.2m/245.9m, Revenue 2.53b/4.40b) |
| GMI: 3.05 (GM 43.54% / 14.28%) |
| AQI: 1.58 (AQ_t 0.08 / AQ_t-1 0.05) |
| SGI: 0.57 (Revenue 2.53b / 4.40b) |
| TATA: -0.01 (NI 58.7m - CFO 103.0m) / TA 3.01b) |
| Beneish M = -0.30 (Cap -4..+1) = D |
As of November 17, 2026, the stock is trading at USD 66.54 with a total of 765,163 shares traded. Over the past week, the price has changed by -3.33%, over one month by +4.54%, over three months by -17.28% and over the past year by -23.39%.
Current recommended Stop Loss: 62.20 (which is 6.5% or 1.8 ATR below the current price).
Cal-Maine Foods has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold CALM.
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 68.3 | 2.7% |
P/E Trailing = 54.0244
P/E Forward = 19.802
P/S = 1.2275
P/B = 1.2079
P/EG = 2.1983
Revenue TTM = 2.53b USD
EBIT TTM = 17.3m USD
EBITDA TTM = 145.5m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.44m USD (Leases only: 1.44m)
Net Debt = -766.1m USD (calculated: Debt 1.44m - CCE 767.6m)
Enterprise Value = 2.34b USD (3.10b + Debt 1.44m - CCE 767.6m)
Interest Coverage Ratio = 31.03 (Ebit TTM 17.3m / Interest Expense TTM 556k)
EV/FCF = -79.20x (Enterprise Value 2.34b / FCF TTM -29.5m)
FCF Yield = -1.26% (FCF TTM -29.5m / Enterprise Value 2.34b)
FCF Margin = -1.17% (FCF TTM -29.5m / Revenue TTM 2.53b)
Net Margin = 2.32% (Net Income TTM 58.7m / Revenue TTM 2.53b)
Gross Margin = 14.28% ((Revenue TTM 2.53b - Cost of Revenue TTM 2.17b) / Revenue TTM)
Gross Margin QoQ = 0.07% (prev 6.16%)
Tobins Q-Ratio = 0.78 (Enterprise Value 2.34b / Total Assets 3.01b)
Interest Expense / Debt = 38.53% (Interest Expense 556k / Debt 1.44m)
Taxrate = 14.61% (10.7m / 73.5m)
NOPAT = 14.7m (EBIT 17.3m * (1 - 14.61%))
Current Ratio = 7.70 (Total Current Assets 1.47b / Total Current Liabilities 191.1m)
Debt / Equity = 0.00 (Debt 1.44m / totalStockholderEquity, last quarter 2.57b)
Debt / EBITDA = -5.27 (Net Debt -766.1m / EBITDA 145.5m)
Debt / FCF = 25.96 (negative FCF - burning cash) (Net Debt -766.1m / FCF TTM -29.5m)
Total Stockholder Equity = 2.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.89% (Net Income 58.7m / Total Assets 3.01b)
RoE = 2.22% (Net Income TTM 58.7m / Total Stockholder Equity 2.65b)
RoCE = 0.61% (EBIT 17.3m / Capital Employed (Total Assets 3.01b - Current Liab 191.1m))
RoIC = 0.55% (NOPAT 14.7m / Invested Capital 2.70b)
WACC = 4.30% (E(3.10b)/V(3.11b) * Re(4.29%) + D(1.44m)/V(3.11b) * Rd(38.53%) * (1-Tc(0.15)))
Discount Rate = 4.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.43 | Cagr: -2.02%
[DCF] Fair Price = unknown (Cash Flow -29.5m)
EPS Correlation: -11.01 | EPS CAGR: -10.24% | SUE: -0.68 | # QB: 0
Revenue Correlation: 40.09 | Revenue CAGR: 11.09% | SUE: -0.19 | # QB: 0
EPS current Quarter (2026-11-30): EPS=-1.00 | Chg30d=-161.04% | Revisions=-40% | Analysts=2
EPS next Quarter (2027-02-28): EPS=-0.56 | Chg30d=-953.85% | Revisions=-40% | Analysts=2
EPS current Year (2027-05-31): EPS=-2.98 | Chg30d=-206.15% | Revisions=-40% | GrowthEPS=-145.9% | GrowthRev=-20.2%
EPS next Year (2028-05-31): EPS=1.01 | Chg30d=-54.18% | Revisions=-40% | GrowthEPS=+134.0% | GrowthRev=+12.4%
[Analyst] Revisions Ratio: -73% (up=0, down=8)